SG Americas Securities
EVH icon

SG Americas Securities’s Evolent Health EVH Stock Holding History

SG Americas Securities’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-57,658
Closed -$131K – 3446
2026
Q1 		$131K Sell
57,658
-40,283
-41% -$128K ﹤0.01% 2826
2025
Q4 		$392K Buy
97,941
+59,991
+158% +$333K ﹤0.01% 2622
2025
Q3 		$321K Buy
37,950
+2,936
+8% +$28.5K ﹤0.01% 2438
2025
Q2 		$394K Buy
+35,014
New +$322K ﹤0.01% 1819
2025
Q1 		– Sell
-20,993
Closed -$236K – 3554
2024
Q4 		$236K Sell
20,993
-10,503
-33% -$185K ﹤0.01% 2004
2024
Q3 		$891K Buy
+31,496
New +$812K ﹤0.01% 1171
2024
Q2 		– Sell
-8,027
Closed -$263K – 2978
2024
Q1 		$263K Buy
8,027
+3,783
+89% +$121K ﹤0.01% 1772
2023
Q4 		$140K Buy
+4,244
New +$120K ﹤0.01% 2476
2023
Q2 		– Sell
-24,236
Closed -$786K – 2543
2023
Q1 		$786K Buy
+24,236
New +$766K 0.01% 1338
2021
Q4 		– Sell
-41,562
Closed -$1.29M – 3510
2021
Q3 		$1.29M Buy
+41,562
New +$998K 0.01% 1682
2021
Q2 		– Sell
-11,993
Closed -$242K – 2952
2021
Q1 		$242K Sell
11,993
-3,456
-22% -$65.7K ﹤0.01% 2541
2020
Q4 		$248K Buy
+15,449
New +$204K ﹤0.01% 2503
2020
Q2 		– Sell
-32,223
Closed -$175K – 3732
2020
Q1 		$175K Buy
+32,223
New +$288K ﹤0.01% 2600
2019
Q1 		– Sell
-162,768
Closed -$3.25M – 3410
2018
Q4 		$3.25M Buy
162,768
+136,731
+525% +$3.16M 0.03% 561
2018
Q3 		$739K Buy
26,037
+13,056
+101% +$311K 0.01% 1902
2018
Q2 		$273K Buy
+12,981
New +$246K ﹤0.01% 2409
2017
Q4 		– Sell
-8,756
Closed -$156K – 3316
2017
Q3 		$156K Buy
+8,756
New +$180K ﹤0.01% 2809

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

SG Americas Securities's EVH Position: Q2 2026 in Review

SG Americas Securities sold out of Evolent Health (EVH) in Q2 2026, closing a stake of 57,658 shares — an estimated $131K sold.

SG Americas Securities first reported a position in EVH in Q3 2017 and held it in 17 quarters. The position peaked at $3.25M in Q4 2018. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • SG Americas Securities reported no remaining Evolent Health position as of Q2 2026 after selling out during the quarter.
  • SG Americas Securities sold 57,658 Evolent Health shares in Q2 2026, an estimated $131K.
  • SG Americas Securities first reported a position in Evolent Health in Q3 2017 and held it in 17 quarters.
  • SG Americas Securities's Evolent Health position peaked at $3.25M in Q4 2018.
  • 198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.